Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
505,000
+1,000 (0.20%)
Apr 10, 2026, 3:30 PM KST
Market Cap11.75T +163.8%
Revenue (ttm)231.81B +9.9%
Net Income5.26B
EPS226.00
Shares Out23.26M
PE Ratio2,232.16
Forward PEn/a
Dividend200.00 (0.04%)
Ex-Dividend DateDec 29, 2025
Volume515,236
Average Volume564,977
Open513,000
Previous Close504,000
Day's Range475,000 - 518,000
52-Week Range127,600 - 1,233,000
Beta2.21
RSI37.04
Earnings DateMay 13, 2026

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1943
Employees 422
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

Financial Statements